А. Yu. Babenko

697 total citations
78 papers, 449 citations indexed

About

А. Yu. Babenko is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Physiology. According to data from OpenAlex, А. Yu. Babenko has authored 78 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Endocrinology, Diabetes and Metabolism, 17 papers in Molecular Biology and 15 papers in Physiology. Recurrent topics in А. Yu. Babenko's work include Diabetes Treatment and Management (19 papers), Diabetes Management and Research (13 papers) and Metabolism, Diabetes, and Cancer (10 papers). А. Yu. Babenko is often cited by papers focused on Diabetes Treatment and Management (19 papers), Diabetes Management and Research (13 papers) and Metabolism, Diabetes, and Cancer (10 papers). А. Yu. Babenko collaborates with scholars based in Russia, United States and Egypt. А. Yu. Babenko's co-authors include Е. V. Shlyakhto, Joseph Bryan, Wanda H. Vila‐Carriles, Lydia Aguilar‐Bryan, Ana Crane, Elena Grineva, Anna Kostareva, O. A. Smolyanskaya, Alexandra N. Ivanova and Jean-Paul Guillet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and International Journal of Molecular Sciences.

In The Last Decade

А. Yu. Babenko

61 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
А. Yu. Babenko Russia 10 162 159 88 73 67 78 449
Kyung Ae Lee South Korea 14 187 1.2× 173 1.1× 101 1.1× 45 0.6× 49 0.7× 52 616
Jordan Morningstar United States 12 124 0.8× 202 1.3× 132 1.5× 91 1.2× 45 0.7× 25 467
Keri A. Kles United States 12 93 0.6× 193 1.2× 91 1.0× 83 1.1× 46 0.7× 14 673
Dan Farbstein Israel 10 111 0.7× 136 0.9× 113 1.3× 56 0.8× 28 0.4× 13 568
Loubna Mhamdi France 9 176 1.1× 203 1.3× 139 1.6× 44 0.6× 49 0.7× 10 533
Freddy Contreras Venezuela 11 105 0.6× 211 1.3× 51 0.6× 83 1.1× 58 0.9× 56 567
Zhaohui Fang China 15 141 0.9× 148 0.9× 49 0.6× 45 0.6× 22 0.3× 56 569
Ryuzo Kawamori Japan 11 138 0.9× 180 1.1× 58 0.7× 81 1.1× 62 0.9× 22 410
Jeļizaveta Sokolovska Latvia 14 168 1.0× 190 1.2× 70 0.8× 38 0.5× 53 0.8× 44 496
Chunying Li United States 10 84 0.5× 112 0.7× 87 1.0× 103 1.4× 16 0.2× 19 419

Countries citing papers authored by А. Yu. Babenko

Since Specialization
Citations

This map shows the geographic impact of А. Yu. Babenko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by А. Yu. Babenko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites А. Yu. Babenko more than expected).

Fields of papers citing papers by А. Yu. Babenko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by А. Yu. Babenko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by А. Yu. Babenko. The network helps show where А. Yu. Babenko may publish in the future.

Co-authorship network of co-authors of А. Yu. Babenko

This figure shows the co-authorship network connecting the top 25 collaborators of А. Yu. Babenko. A scholar is included among the top collaborators of А. Yu. Babenko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with А. Yu. Babenko. А. Yu. Babenko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Babenko, А. Yu., et al.. (2024). Patient and glucometer: how can glucose self-monitoring be improved?. Meditsinskiy sovet = Medical Council. 130–137.
2.
Babenko, А. Yu., et al.. (2024). Role of Brown Adipose Tissue in Metabolic Health and Efficacy of Drug Treatment for Obesity. Journal of Clinical Medicine. 13(14). 4151–4151. 3 indexed citations
3.
Babenko, А. Yu., et al.. (2024). Brown and Beige Adipose Tissue: One or Different Targets for Treatment of Obesity and Obesity-Related Metabolic Disorders?. International Journal of Molecular Sciences. 25(24). 13295–13295. 6 indexed citations
4.
Babenko, А. Yu., et al.. (2023). Predictors of Carbohydrate Metabolism Disorders and Lethal Outcome in Patients after Myocardial Infarction: A Place of Glucose Level. Journal of Personalized Medicine. 13(6). 997–997.
5.
Babenko, А. Yu., et al.. (2022). Problems of blood glucose self-monitoring in patients with diabetes mellitus. SHILAP Revista de lepidopterología. 140–148. 3 indexed citations
6.
7.
8.
Babenko, А. Yu., et al.. (2021). Comparison of the effects of liraglutide and sibutramine in obese patients. SHILAP Revista de lepidopterología. 18(2). 218–228. 7 indexed citations
9.
Sitnikova, M. Yu., et al.. (2021). Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2021. 1–8. 7 indexed citations
10.
Babenko, А. Yu., et al.. (2021). SCALE FOR SCORING THE SEVERITY OF FUNCTIONAL IMPAIRMENT OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH DIABETES MELLITUS. Bulletin of Pirogov National Medical & Surgical Center. 16(3). 18–24.
11.
Babenko, А. Yu., et al.. (2020). Interrelations of components of metabolic syndrome with the level of the hormones involved in regulation of adipose tissue metabolism. Arterial’naya Gipertenziya (Arterial Hypertension). 25(6). 639–652. 2 indexed citations
12.
Babenko, А. Yu., et al.. (2020). Type 2 Diabetes Mellitus and Chronic Heart Failure with Midrange and Preserved Ejection Fraction: A Focus on Serum Biomarkers of Fibrosis. Journal of Diabetes Research. 2020. 1–9. 19 indexed citations
13.
14.
Babenko, А. Yu., et al.. (2020). Diabetes mellitus and COVID-19. How are they connected? Current strategy of fight. Arterial’naya Gipertenziya (Arterial Hypertension). 26(3). 304–311. 2 indexed citations
15.
Babenko, А. Yu., et al.. (2019). Biomarkers associated with atherogenesis: current status and promising areas. SHILAP Revista de lepidopterología. 148–152. 4 indexed citations
16.
Smolyanskaya, O. A., Ekaterina N. Lazareva, Nikolay V. Petrov, et al.. (2019). Multimodal Optical Diagnostics of Glycated Biological Tissues. Biochemistry (Moscow). 84(S1). 124–143. 21 indexed citations
17.
Babenko, А. Yu., et al.. (2019). Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity. Journal of Diabetes Research. 2019. 1–12. 23 indexed citations
18.
19.
Babenko, А. Yu., et al.. (2015). Diabetes and bone. Focus on DPP-4 inhibitors. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Babenko, А. Yu., et al.. (2015). Diabetic nephropathy. Is renoprotection determined by the choice of hypoglycemic therapy?. SHILAP Revista de lepidopterología. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kyung Ae Lee Breakdown of academic impact, for papers by Jordan Morningstar Breakdown of academic impact, for papers by Keri A. Kles Breakdown of academic impact, for papers by Dan Farbstein Breakdown of academic impact, for papers by Loubna Mhamdi Breakdown of academic impact, for papers by Freddy Contreras Breakdown of academic impact, for papers by Zhaohui Fang Breakdown of academic impact, for papers by Ryuzo Kawamori Breakdown of academic impact, for papers by Jeļizaveta Sokolovska Breakdown of academic impact, for papers by Chunying Li
Rankless by CCL
2026